Xingguang Liu Selected Research

Virus Diseases (Viral Diseases)

1/2020	Methyltransferase Dot1l preferentially promotes innate IL-6 and IFN-β production by mediating H3K79me2/3 methylation in macrophages.
1/2019	KAT8 selectively inhibits antiviral immunity by acetylating IRF3.
1/2019	Interferon-inducible cytoplasmic lncLrrc55-AS promotes antiviral innate responses by strengthening IRF3 phosphorylation.
10/2015	Phosphatase PP4 Negatively Regulates Type I IFN Production and Antiviral Innate Immunity by Dephosphorylating and Deactivating TBK1.
11/2010	Inducible microRNA-155 feedback promotes type I IFN signaling in antiviral innate immunity by targeting suppressor of cytokine signaling 1.
8/2009	MicroRNA-146a feedback inhibits RIG-I-dependent Type I IFN production in macrophages by targeting TRAF6, IRAK1, and IRAK2.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Xingguang Liu Research Topics

Disease

10	Neoplasms (Cancer) 01/2022 - 10/2006
7	Inflammation (Inflammations) 01/2022 - 12/2007
6	Virus Diseases (Viral Diseases) 01/2020 - 08/2009
5	Vesicular Stomatitis 10/2015 - 08/2009
4	Neoplasm Metastasis (Metastasis) 03/2019 - 10/2006
3	Squamous Cell Carcinoma of Head and Neck 04/2022 - 11/2015
3	Carcinogenesis 04/2022 - 01/2013
3	Myocardial Infarction 01/2022 - 01/2019
3	Infections 01/2020 - 08/2009
3	Septic Shock (Toxic Shock Syndrome) 01/2020 - 05/2011
2	Reperfusion Injury 01/2022 - 01/2017
2	Bacterial Infections (Bacterial Infection) 11/2018 - 07/2011
2	Colonic Neoplasms (Colon Cancer) 01/2009 - 01/2008
1	Heart Failure 01/2022
1	Fibrosis (Cirrhosis) 01/2022
1	Hypoxia (Hypoxemia) 01/2022
1	Wounds and Injuries (Trauma) 04/2021
1	Pneumonia (Pneumonitis) 04/2021
1	Colitis 01/2020
1	Myocardial Ischemia (Ischemic Heart Diseases) 04/2019
1	Carcinoma (Carcinomatosis) 03/2019
1	Papillary Thyroid Cancer 06/2017
1	Porcine Reproductive and Respiratory Syndrome (PRRS) 01/2016
1	Head and Neck Neoplasms (Head and Neck Cancer) 11/2015
1	Sepsis (Septicemia) 04/2012
1	Hepatocellular Carcinoma (Hepatoma) 10/2011
1	RNA Virus Infections 11/2010
1	Breast Neoplasms (Breast Cancer) 10/2006

Drug/Important Bio-Agent (IBA)

7	Proteins (Proteins, Gene)FDA Link 01/2021 - 01/2008
5	Toll-Like Receptors (Toll-Like Receptor)IBA 01/2020 - 04/2012
4	Long Noncoding RNAIBA 04/2022 - 07/2018
4	MicroRNAs (MicroRNA)IBA 04/2021 - 11/2010
4	Interferon Type IIBA 01/2019 - 05/2011
4	CytokinesIBA 11/2018 - 12/2007
3	Calcium-Calmodulin-Dependent Protein Kinase Type 2IBA 01/2021 - 01/2008
3	Interleukin-6 (Interleukin 6)IBA 01/2020 - 01/2016
3	LigandsIBA 01/2020 - 02/2014
3	Antiviral Agents (Antivirals)IBA 10/2015 - 08/2009
2	Phosphoric Monoester Hydrolases (Phosphatases)IBA 03/2020 - 01/2019
2	InterferonsIBA 01/2020 - 07/2011
2	Transcription Factors (Transcription Factor)IBA 01/2019 - 01/2013
2	Interferon Regulatory Factor-3 (Interferon Regulatory Factor 3)IBA 01/2019 - 10/2015
2	TNF Receptor-Associated Factor 6 (TRAF6)IBA 01/2017 - 08/2009
1	Cisplatin (Platino)FDA LinkGeneric 04/2022
1	Doxorubicin (Adriamycin)FDA LinkGeneric 01/2022
1	Phosphoprotein Phosphatases (Phosphatases, Protein)IBA 01/2022
1	Leucine-Rich Repeat ProteinsIBA 01/2022
1	LipopolysaccharidesIBA 04/2021
1	Small Nucleolar RNA (snoRNA)IBA 04/2021
1	MethyltransferasesIBA 01/2020
1	Biomarkers (Surrogate Marker)IBA 09/2019
1	CollagenIBA 03/2019
1	E-SelectinIBA 11/2018
1	Cytokine Receptors (Cytokine Receptor)IBA 11/2018
1	condensin complexes (condensin)IBA 01/2018
1	DNA (Deoxyribonucleic Acid)IBA 01/2018
1	IodineIBA 06/2017
1	Pattern Recognition ReceptorsIBA 01/2016
1	Telomerase (Telomerase Reverse Transcriptase)IBA 11/2015
1	Histocompatibility Antigens Class IIBA 04/2012
1	CholesterolIBA 10/2011
1	Fetal Proteins (Fetoprotein)IBA 10/2011
1	Tretinoin (Retinoic Acid)FDA LinkGeneric 11/2010
1	Biological ProductsIBA 11/2010
1	Carrier Proteins (Binding Protein)IBA 06/2010
1	Nucleic AcidsIBA 06/2010
1	Interferon-betaIBA 06/2010
1	Fas-Associated Death Domain Protein (Fas-Associating Protein with Death Domain)IBA 08/2009
1	NF-kappa B (NF-kB)IBA 08/2009
1	Mitogen-Activated Protein Kinase Kinases (MEKs)IBA 01/2009
1	Small Interfering RNA (siRNA)IBA 10/2006
1	Adenosine Triphosphatases (ATPase)IBA 10/2006

Therapy/Procedure

5	Therapeutics 09/2019 - 01/2008
2	Drug Therapy (Chemotherapy) 01/2022 - 11/2015
1	Immunotherapy 01/2022